Clarifying the role of a protein released by immune 'dendritic' cells could yield better treatments

August 30, 2018, Agency for Science, Technology and Research (A*STAR), Singapore
Artistic rendering of the surface of a human dendritic cell illustrating sheet-like processes that fold back onto the membrane surface. Credit: National Institutes of Health (NIH)

Inflammatory bowel disease (IBD), which afflicts millions of people worldwide, arises when the immune system mounts an overly aggressive response against microorganisms, dietary substances, or cells of the gut. A*STAR researchers have identified specific cells and molecular signals that maintain appropriate immune activity, and that may be disrupted when IBD develops. The insights open possibilities for new treatments to combat IBD.

The human intestine carries a complex mixture of microorganisms: some benefit the digestive system and general health, while others can cause serious illness. The cells of the immune system need to balance responding effectively to attack harmful infections in the gut with tolerating harmless microorganisms and other gut contents. If the immune response is over-aggressive, it causes the intestinal inflammation that leads to the symptoms of chronic IBD.

"We discovered that interleukin-2 protein secreted by specialized immune cells, called , in the intestinal lining, keep inflammation in check," says Alessandra Mortellaro of the A*STAR Singapore Immunology Network. She explains that interleukin-2 released by dendritic cells achieves this effect by suppressing the activity of other immune system cells called inflammatory T-cells. In a further demonstration of the sophisticated immune control network, the dendritic cell interleukin-2 also promotes the generation of other specialized T cells that suppress the immune response.

Interleukin-2 is released by many types of cells in the body, including dendritic and T-cells. To clarify the specific role of interleukin-2 released by dendritic cells, the A*STAR team sought a way to separate the effects of different sources of the protein. "To achieve this, we generated mice that did not specifically produce interleukin-2 from dendritic cells," says Mortellaro. These mice suffered severe and spontaneous intestinal inflammation.

The researchers also discovered that the mice had a different form of inflammation than mice in which interleukin-2 production was knocked out from both dendritic cells and T-cells. Finding that the dendritic cell interleukin-2 performs distinct and specific functions "was a real breakthrough moment," explains Mortellaro. The processes in mice are assumed to be similar to those in humans.

By unraveling molecular details of the signaling systems to reveal the specific and previously unknown role of interleukin-2 from dendritic cells, the researchers hope to prompt new research into possibilities for treatment. One option could be finding ways to specifically boost interleukin-2 production by dendritic cells. The researchers also want to understand if dendritic cell interleukin-2 regulation is involved in other inflammatory and autoimmune diseases affecting tissues such as the skin.

Explore further: Study provides insights on immune cells involved in kidney disease

More information: Andrea Mencarelli et al. Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis, Nature Communications (2018). DOI: 10.1038/s41467-018-03495-3

Related Stories

Study provides insights on immune cells involved in kidney disease

December 7, 2017
Researchers have uncovered new information on cells involved in the body's immune response following kidney injury. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology (JASN), ...

Mysteries of the developing immune system have been revealed in a study of fetal dendritic cells

December 19, 2017
The fetal immune system is fully developed and functional from as early as 16 weeks gestation, but has a mechanism to keep it suppressed until after birth, according to an A*STAR-led study. Their findings could shed light ...

'Hidden' driver discovered that helps prime the anti-tumor immune response

May 30, 2018
Like exposing a crime boss whose authority has gone undetected, St. Jude Children's Research Hospital scientists have identified a hidden driver that influences production of the T cells that fight cancer and infections. ...

Salt, inflammation and hypertension

November 14, 2017
Although dietary salt intake positively correlates with blood pressure, the mechanisms linking salt to hypertension are not well understood.

Scientists discover endogenous dendritic cell-derived interleukin-27 promotes tumor growth

May 1, 2014
In a new report published in the Journal of Leukocyte Biology, scientists lay the groundwork for the development of novel tumor therapies that may help rid the body of cancer by inhibiting the recruitment of a specific suppressive ...

Intestinal immune cells play an unexpected role in immune surveillance of the bloodstream

December 13, 2012
A type of immune cell found in the small intestine plays a previously unsuspected role in monitoring antigens circulating in the bloodstream. The findings from a team of Massachusetts General Hospital (MGH) researchers clarify ...

Recommended for you

Study reviews what causes chronic itching and scratching

November 21, 2018
Relentless itch is a feature of many skin disorders, such as eczema and psoriasis, but the cause of this itch—and what drives us to scratch—is somewhat mysterious. A review appearing November 21 in the journal Trends ...

Regulating the immune system's 'regulator'

November 20, 2018
A research team at the Academy of Immunology and Microbiology, within the Institute for Basic Science (IBS) has discovered a possible therapeutic target that pulls the reins of immunity. In Nature Communications, the scientists ...

New immunotherapy improves MS symptoms

November 20, 2018
A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has improved symptoms and quality of life for the majority of patients.

Scientists unveil completely human platform for testing age-specific vaccine responses

November 20, 2018
A team of scientists at Boston Children's Hospital has developed the first modeling system for testing age-specific human immune responses to vaccines—outside the body. The practical, cost-effective new platform, using ...

To resolve inflammation, location matters

November 19, 2018
Health conditions that involve inflammation run the gamut, from multiple sclerosis and lupus to arthritis, diabetes, and cancer. While inflammation can serve as a normal response to help the body deal with injury or infection, ...

New insights into how an ordinary stem cell becomes a powerful immune agent

November 19, 2018
How do individual developing cells choose and commit to their "identity"—to become, for example, an immune cell, or a muscle cell, or a neuron?

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.